01-01-1970 12:00 AM | Source: Dion Global Solutions Ltd
AstraZeneca Pharma India Q4 net profit up 2.57% at Rs 27.98 cr
News By Tags | #2733 #642 #1302 #572

Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel

https://t.me/InvestmentGuruIndiacom

Download Telegram App before Joining the Channel

The company reported standalone net profit of Rs 27.98 crore for the quarter ended March 31, 2022 as compared to Rs 27.28 crore in the same period last year, registering a year-on-year growth of 2.57 per cent. Net revenue of the company rose moderately by 10.32 per cent at Rs 231.96 crore in January-March quarter of this fiscal as against Rs 210.26 crore in the corresponding period last year. During January-March quarter, operating expenses increased by 14.22 per cent to Rs 194.00 crore from Rs 169.85 crore in year ago period.

Other Income grew by 44.31 per cent at Rs 3.68 crore versus (Mar'21 Rs 2.55 crore). Operating Profit slipped by 6.06 per cent to Rs 37.96 crore as against Rs 40.41 crore in the year ago period, while Operating Profit Margin (OPM) contracted year-on-year to 14.88 per cent in March quarter. Interest declined by 25.00 per cent y-o-y to Rs 0.21 crore, while Taxation decreased by 5.33 per cent at Rs 9.05 crore (Mar'21 Rs 9.56 crore).